BRIEF published on 06/26/2024 at 15:31, 4 months 26 days ago Dalata Hotel Group PLC: Notification of Major Holdings Voting Rights Dalata Hotel Group Stock Acquisition Franklin Mutual Advisers
PRESS RELEASE published on 06/26/2024 at 15:26, 4 months 26 days ago Dalata Hotel Group PLC: HOL-Holding(s) in Company* Dalata Hotel Group PLC notified of holding above 5% of voting rights by Franklin Mutual Advisers, LLC from the United States Voting Rights Notification Dalata Hotel Group Plc Shareholder Disclosure Franklin Mutual Advisers LLC
BRIEF published on 06/25/2024 at 12:32, 4 months 27 days ago Dalata Hotel Group PLC: Major Holdings Notification Voting Rights Major Holdings FMR LLC Dalata Hotel Group
PRESS RELEASE published on 06/25/2024 at 12:27, 4 months 27 days ago Dalata Hotel Group PLC: HOL-Holding(s) in Company* FMR LLC notifies holding of 8.96% in Dalata Hotel Group PLC to the Central Bank of Ireland as per TR-1 form Voting Rights Notification FMR LLC Dalata Hotel Group Plc Holding
BRIEF published on 06/04/2024 at 10:52, 5 months 19 days ago Dalata Hotel Group PLC: HOL-Holding(s) Notification Voting Rights Shareholding Dalata Hotel Group Financial Notification GLG Partners LP
PRESS RELEASE published on 06/04/2024 at 10:47, 5 months 19 days ago Dalata Hotel Group PLC: HOL-Holding(s) in Company* GLG Partners LP has notified a holding of less than 3% of voting rights in Dalata Hotel Group PLC as of 31/05/2024 Major Holdings Notification Dalata Hotel Group Plc HOL-Holding GLG Partners LP
BRIEF published on 06/04/2024 at 10:35, 5 months 19 days ago Dalata Hotel Group PLC Announces Total Voting Rights Shareholders Total Voting Rights Dalata Hotel Group Transparency Regulations
PRESS RELEASE published on 06/04/2024 at 10:30, 5 months 19 days ago Dalata Hotel Group PLC: TVR-Total Voting Rights Dalata Hotel Group PLC announces total voting rights as of 4 June 2024. Share capital consists of 224,430,160 Ordinary Shares, no shares in treasury. Shareholders can use this figure for Transparency Directive calculations Shareholders Stock Exchange Total Voting Rights Dalata Hotel Group Plc Transparency Directive
BRIEF published on 05/30/2024 at 13:20, 5 months 23 days ago Dalata Hotel Group PLC: Significant Holdings Notification Voting Rights Major Shareholding Financial Instruments Dalata Hotel Group Helikon Investments
PRESS RELEASE published on 05/30/2024 at 13:15, 5 months 23 days ago Dalata Hotel Group PLC: HOL-Holding(s) in Company* Helikon Investments Limited, based in London, UK, crosses 6% threshold in Dalata Hotel Group PLC as of 27th May 2024 Major Holdings Notification Dalata Hotel Group Plc London Financial Instruments Helikon Investments Limited
Published on 11/22/2024 at 23:55, 11 hours 34 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 11 hours 59 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 12 hours 24 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 12 hours 59 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 17 hours 14 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 17 hours 35 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 18 hours 33 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 19 hours 29 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 4 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 16 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 17 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 17 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
